D Myny1, P Depuydt, F Colardyn, S Blot. 1. Ghent University Hospital, Intensive Care Department, De Pintelaan 185 B-9000, Ghent, Belgium. dries.myny@uzgent.be
Abstract
OBJECTIVE: To investigate the incidence, risk factors and mortality of ventilator-associated pneumonia (VAP) in intensive care unit (ICU) patients. DESIGN: Prospective, observational, population-based study. SETTING: The medical (14-bed) and surgical ICU (26-bed) of the Ghent University Hospital. METHODS: All 1295 patients admitted to the ICU during 4 three-month periods between 1996 and 1998 were included. A set of demographic and clinical variables were collected at the day of admission and during the ICU course. RESULTS: The incidence of VAP among ICU patients ventilated at least 48 hours was 23.1%. The mean time to the development of VAP was 9.6 days with a median of 6 days. In the population of patients ventilated for at least 48 hours, a comparison was made between patients with (n = 89) and without VAP (n = 296). Patients with VAP had a significant longer ICU stay, with a longer ventilation dependency. Logistic regression analysis identified admission diagnosis other than trauma (OR: 0.51, 95% CI: 0.29-0.89; p = 0.02) and the length of ICU stay (OR: 1.05, 95% CI: 1.03-1.07; p < 0.001) to be independently associated with the acquisiton of VAP. In comparison with the total study population, patients with VAP had a higher ICU mortality (20.2% vs. 12.0%; p = 0.04), but not in the cohort group of patients at risk for VAP (ventilated > 48 hours)(20.2% vs. 31.3%; p = 0.03). The factors independently associated with death were higher SAPS II scores (OR 1.02, 95% CI: 1.003-1.032; p = 0.02), an admission diagnosis other than trauma (OR 0.36, 95% CI: 0.17-0.75; p = 0.006) and length of ICU stay (OR 0.97, 95% CI: 0.946-0.995; p = 0.02). This model did not recognize VAP as an independent predictor of death (OR 0.79, 95% CI: 0.41-1.53; p = 0.492). CONCLUSIONS: The incidence of VAP in our ICU is 23.1%. Length of ICU stay and an admission diagnosis other than trauma are major risk factors for the development of this nosocomial infection. VAP is associated with a high fatality rate. However, after adjustment for disease severity and length of ICU stay, VAP was not identified as an independent predictor of death.
OBJECTIVE: To investigate the incidence, risk factors and mortality of ventilator-associated pneumonia (VAP) in intensive care unit (ICU) patients. DESIGN: Prospective, observational, population-based study. SETTING: The medical (14-bed) and surgical ICU (26-bed) of the Ghent University Hospital. METHODS: All 1295 patients admitted to the ICU during 4 three-month periods between 1996 and 1998 were included. A set of demographic and clinical variables were collected at the day of admission and during the ICU course. RESULTS: The incidence of VAP among ICU patients ventilated at least 48 hours was 23.1%. The mean time to the development of VAP was 9.6 days with a median of 6 days. In the population of patients ventilated for at least 48 hours, a comparison was made between patients with (n = 89) and without VAP (n = 296). Patients with VAP had a significant longer ICU stay, with a longer ventilation dependency. Logistic regression analysis identified admission diagnosis other than trauma (OR: 0.51, 95% CI: 0.29-0.89; p = 0.02) and the length of ICU stay (OR: 1.05, 95% CI: 1.03-1.07; p < 0.001) to be independently associated with the acquisiton of VAP. In comparison with the total study population, patients with VAP had a higher ICU mortality (20.2% vs. 12.0%; p = 0.04), but not in the cohort group of patients at risk for VAP (ventilated > 48 hours)(20.2% vs. 31.3%; p = 0.03). The factors independently associated with death were higher SAPS II scores (OR 1.02, 95% CI: 1.003-1.032; p = 0.02), an admission diagnosis other than trauma (OR 0.36, 95% CI: 0.17-0.75; p = 0.006) and length of ICU stay (OR 0.97, 95% CI: 0.946-0.995; p = 0.02). This model did not recognize VAP as an independent predictor of death (OR 0.79, 95% CI: 0.41-1.53; p = 0.492). CONCLUSIONS: The incidence of VAP in our ICU is 23.1%. Length of ICU stay and an admission diagnosis other than trauma are major risk factors for the development of this nosocomial infection. VAP is associated with a high fatality rate. However, after adjustment for disease severity and length of ICU stay, VAP was not identified as an independent predictor of death.
Authors: Jordi Rello; Despoina Koulenti; Stijn Blot; Rafael Sierra; Emili Diaz; Jan J De Waele; Antonio Macor; Kemal Agbaht; Alejandro Rodriguez Journal: Intensive Care Med Date: 2007-03-24 Impact factor: 17.440
Authors: Stijn I Blot; Sonia Labeau; Dominique Vandijck; Paul Van Aken; Brigitte Claes Journal: Intensive Care Med Date: 2007-06-01 Impact factor: 17.440
Authors: Andrew M Naidech; Bernard R Bendok; Paul Tamul; Sarice L Bassin; Charles M Watts; H Hunt Batjer; Thomas P Bleck Journal: Neurocrit Care Date: 2008-09-27 Impact factor: 3.210
Authors: S V Yakovlev; L S Stratchounski; G L Woods; B Adeyi; K A McCarroll; J A Ginanni; I R Friedland; C A Wood; M J DiNubile Journal: Eur J Clin Microbiol Infect Dis Date: 2006-10 Impact factor: 3.267
Authors: D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-25 Impact factor: 3.267
Authors: Dominique M Vandijck; Eric A Hoste; Stijn I Blot; Pieter O Depuydt; Renaat A Peleman; Johan M Decruyenaere Journal: BMC Infect Dis Date: 2007-09-14 Impact factor: 3.090
Authors: Martin Wolkewitz; Ralf Peter Vonberg; Hajo Grundmann; Jan Beyersmann; Petra Gastmeier; Sina Bärwolff; Christine Geffers; Michael Behnke; Henning Rüden; Martin Schumacher Journal: Crit Care Date: 2008-04-02 Impact factor: 9.097